Skip to main content
Immunity, Inflammation and Disease logoLink to Immunity, Inflammation and Disease
. 2022 May 11;10(6):e632. doi: 10.1002/iid3.632

Epidemiology of rhinovirus under the COVID‐19 pandemic in Guangzhou, China, 2020

Jianyun Lu 1, Tiantian Wu 2, Qing Zeng 3, Yiyun Chen 3, Yanhui Liu 3, Di Wu 3,
PMCID: PMC9092004  PMID: 35634957

Abstract

Background

To analyze the epidemic characteristics of the human rhinovirus (HRV) outbreaks in Guangzhou, China, in 2020.

Methods

Descriptive epidemiological methods were used to analyze the HRV‐related outbreaks in Guangzhou, 2020.

Results

Seventeen outbreaks were reported in 2020 during the coronavirus disease 2019 (COVID‐19) pandemic in Guangzhou, a total of 465 patients (290 males and 175 females) were enrolled, with a median age of 10. A total of 223 (47.96%) had been tested for HRV, 89 (39.91%) of which were positive; 344/465 (73.98%) had a fever, 138/465 (29.68%) had a runny nose, 139/465 (29.89%) had a sore throat, 86/465 (18.49%) had a cough, 41/465 (8.82%) had a headache, and 37/465 (7.96%) had a sneeze. Patients at age of 13–15 had the highest rate of sore throat and runny nose, patients aged 11–12 had the highest rate of sneezing, and patients at age of 12–14 had the highest rate of positive rate. Patients tested positive had a higher rate of fever (χ2  = 11.271, p = .001), cough (χ2  = 6.987, p = .008), runny nose (χ2  = 7.980, p = .005), and sneeze (χ2  = 4.676, p = .031).

Conclusion

The HRV was restored during the fighting of the COVID‐19 pandemic. The conventional COVID‐19 control measures were not effective enough in preventing rhinovirus. More appropriate control measures should be used to control HRV.

Keywords: coronavirus disease 2019, human rhinovirus, outbreaks, pandemic, severe acute respiratory syndrome coronavirus 2

1. BACKGROUND

Human rhinoviruses (HRV) are the most common pathogens of the “common cold,” and caused more than half of the “common cold” was caused by HRV. 1 HRV was designated as A, B, and C groups, within the genus Enterovirus and the family Picornaviridae. 2 The main symptoms of the “cold” caused by HRV infection are low fever, cough, runny nose, and so forth, and was a self‐limited disease in most conditions. 3 The coronavirus disease 2019 (COVID‐19) pandemic has led to an unprecedented level of concern about fever cases. The most common strategy for the control of the unexplained fever event during the COVID‐19 pandemic was to test for the nucleic acid of the severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) and influenza virus (IFV); however, we detected and found both SARS‐COV‐2 and influenza were negative and proved to be HRV infection finally. Studies have reported that interference among respiratory viruses could affect the infection of the host at a large scale population level, 4 , 5 , 6 IFV was the most observed and studied respiratory virus, Wu et al. 7 found that rhinovirus disrupted the 2019 influenza A virus (IAV) pandemic in Europe and indicated that the respiratory viral interference can potentially affect the seasonal influenza epidemics and ongoing COVID‐19 pandemic. Piret and Boivin 8 reported that HRV could reduce the likelihood of coinfection with IAV and reduce SARS‐COV‐2 replication in human airway epithelial cells. We analyzed the outbreaks of the HRV infection in Guangzhou, China, during the fight against the COVID‐19 pandemic, enhanced the understanding of the prevention and control of rhinovirus outbreaks, and thus provide better evidence for the interference of the respiratory virus during the COVID‐19 pandemic, and thus control the pandemic.

2. METHODS

2.1. Data and specimen collection

We collected all the information on the fever events of unknown cause during the combatting of the COVID‐19 pandemic in Guangzhou, 2020. Throat swabs or nasopharyngeal swabs were taken during all outbreaks of the fever events during the field investigation and were tested in the laboratory of the Guangzhou Center for Disease Control and Prevention.

2.2. Case definition

The cases enrolled in the study are the ones with one of these symptoms since the first case and before the last case was reported: fever, cough, runny nose, sneezing, or sore throat. If there were more than five cases reported in 3 days in a class should be defined as an outbreak.

2.3. Etiological detection

During the field investigation, throat swabs were collected from patients who did not take antiviral drugs within 3 days of onset and met the case definition. SARS‐COV‐2 and influenza nucleic acid were tested by real‐time quantitative polymerase chain reaction within 6 h after the samples were collected, and NxTAG Respiratory Pathogen Panel (LOT: XK051C‐1045; Luminex) was used to test for the respiratory polypathogen nucleic acid. IFV (subtype AH1, AH3), A (H1N1)pdm09, influenza B virus, respiratory syncytial virus (RSV), parainfluenza virus (PIV; 1, 2, 3, 4), bocavirus, human metapneumovirus (HMPV), HRV, adenovirus (ADV), coronavirus (OC43, 229E, HKU‐1, NL63), legionella, mycoplasma pneumonia, and chlamydia pneumonia were included. All tests were followed by the manufacturers' instructions.

2.4. Statistical analysis

Excel 2019 was used to collect the basic information about the patients in the outbreaks during the field investigation. χ test was used for statistical analysis using SPSS statistics (version 13.0), p < .05 was considered to be significant.

3. RESULTS

3.1. General information

Guangzhou is the capital city of Guangdong Province, China, with an 18.6 million population. We have detected 17 outbreaks of HRV in 2020, a total of 465 cases have been reported, of which, 290 were male and 175 were female, with an average age of 11.9 and the median age was 10.

3.2. Temporal and spatial epidemiology

Of all the 17 outbreaks, six were reported in June, three were reported in July, five were reported in September, one was reported in October, and two were reported in November. All outbreaks were reported in schools, 8 out of 17 were reported in primary school, six were reported in vocational education school, two were in kindergarten, and one in middle school (Table 1).

TABLE 1.

Temporal and spatial epidemiology of the HRV outbreaks in Guangzhou.

School School type Time No. of cases
School 1 Primary school June 14
School 2 Middle school June 16
School 3 Vocational education school June 16
School 4 Primary school June 21
School 5 Primary school June 40
School 6 Primary school June 55
School 7 Vocational education school July 9
School 8 Vocational education school July 29
School 9 Primary school July 28
School 10 Vocational education school September 87
School 11 Kindergarten September 6
School 12 Kindergarten September 60
School 13 Primary school September 34
School 14 Primary school September 9
School 15 Vocational education school October 23
School 16 Primary school November 5
School 17 Vocational education school November 13

Abbreviation: HRV, human rhinovirus.

3.3. Etiological detection

Of all the 465 cases, 223 (47.96%) had been taken specimens and tested, all negative for SARS‐COV‐2 and influenza, of which, 89 (39.91%) were tested positive for HRV without genotyping.

3.4. Clinical characteristics of the patients in the outbreaks

We collected all the core health indicators of the enrolled patients, such as age, sex, the temperature of the patients, and the symptoms of the patients: cough, sore throat, muscle pain, headache, conjunctival congestion, runny nose, sneezing, diarrhea, and vomit.

We analyzed and found the average age of all the patients is 11.9 ± 5.9 years, and the median age is 10. A total of 290 males and 175 females were enrolled, 344/465 (73.98%) had a record of temperature over 37.3°C, 138/465 (29.68%) had a runny nose, 139/465 (29.89%) had a sore throat, 86/465 (18.49%) had cough, 41/465 (8.82%) had a headache, 37/465 (7.96%) had sneezed, and we found the female patients had a higher rate of having fever and more likely to be tested positive for the HRV test (Table 2). Notably, 7/465 (1.51%) had muscle pain, 5/465 (1.08%) had diarrhea, 1/465 (0.22%) had conjunctival congestion, and 1/465 (0.22%) had vomit.

TABLE 2.

Sex‐specific clinical characteristics of the patients.

Characteristics Sex Total N (%) a
Male N (%) a Female (%) a
Total 290 (100) 175 (100) 465 (100)
Fever 200 (68.97) 144 (82.29) 344 (73.98)
Cough 56 (19.31) 30 (17.14) 86 (18.49)
Sore throat 85 (29.31) 54 (30.86) 139 (29.89)
Runny nose 84 (28.97) 54 (30.86) 138 (29.68)
Sneeze 23 (7.93) 14 (8.00) 37 (7.96)
HRV test
Without test 146 96 242
Negative 91 43 134
Positive 53 (36.81)b 36 (45.57)b 89 (39.91)b

Abbreviation: HRV, human rhinovirus.

a

The percentage was the rate of the patients with the symptom in total of males or females.

b

The percentage was the positive rate of the tested males and females.

We next analyzed the results by age group and found the patients less than 5 years old had the highest rate of having fever, and if the patients had an elder age will have less rate of having a fever, but the patients over 18 had the opposite trend. The patients aged 9–10 had the highest rate of cough. Patients at the age of 13–15 had the highest rate of sore throat and runny nose, patients at the age of 11–12 had the highest rate of sneezing, and patients at age of 12–14 had the highest rate of positive rate (Table 3).

TABLE 3.

Age‐specific clinical characteristics of the patients.

Age

Total cases

N

Fever N (%)a

Cough

N (%)

Sore throat

N (%)

Runny nose

N (%)

Sneeze

N (%)

HRV test

Without test

N

Negative

N

Positive N (%)b
<5 54 49 (90.74) 4 (7.41) 4 (7.41) 0 (0) 0 (0) 36 12 6 (33.33)
<8 82 62 (75.61) 7 (8.54) 20 (24.39) 28 (34.15) 5 (6.1) 50 23 9 (28.13)
<10 79 56 (70.89) 28 (35.44) 32 (40.51) 35 (44.3) 13 (16.56) 30 26 23 (46.94)
<12 47 32 (68.09) 6 (12.77) 21 (44.68) 20 (42.55) 9 (19.15) 17 19 11 (36.67)
<15 25 15 (60.00) 7 (28.00) 13 (52.00) 13 (52.00) 4 (16.00) 12 2 11 (84.62)
<18 42 21 (50.00) 16 (38.1) 12 (28.57) 18 (42.86) 3 (7.14) 14 15 13 (46.43)
<20 72 53 (73.61) 10 (13.89) 16 (22.22) 14 (19.44) 0 (0) 35 22 15 (40.54)
≥ 20 64 56 (87.5) 8 (12.5) 21 (32.81) 10 (15.36) 3 (4.69) 48 15 1 (6.25)
Total 465 344 (73.98) 86 (18.49) 139 (29.89) 138 (29.68) 37 (7.96) 242 134 89 (39.91)

Abbreviation: HRV, human rhinovirus.

a

The patients with a body temperature ≥37.3°C are defined as having fever.

b

The percentage was the positive rate of the tested patients.

We next found that the tested patients had a statistically lower rate of fever than that of the patients without test (χ 2 = 32.563, p < .001), which might be due to our preference to take specimens of the cases with symptoms such as fever during field investigations. The rest of the clinical characteristics were no statistical difference between the tested and not tested ones (Table 4).

TABLE 4.

The clinical characteristics of the patients in the outbreaks.

HRV tested Without HRV tested χ 2 P
Age
Average 11.94 11.86
Sex
Male 144 (64.6) 146 (60.3) 0.890 .345
Female 79 (35.4) 96 (39.7)
Fever
No 128 (38.1) 36 (14.9) 32.563 <.001
Yes 95 (61.9) 206 (85.1)
Cough
No 188 (84.3) 191 (78.9) 2.228 .136
Yes 35 (15.7) 51 (21.1)
Sore throat
No 165 (74.0) 161 (66.5) 3.084 .079
Yes 58 (26.0) 81 (33.5)
Muscle pain
No 222 (99.6) 236 (97.5) 3.228 .072
Yes 1 (0.4) 6 (2.5)
Headache
No 205 (91.9) 219 (90.5) 0.296 .586
Yes 18 (8.1) 23 (9.5)
Conjunctival congestion
No 223 (100.0) 241 (99.6) 0.923 .337
Yes 0 (0) 1 (0.4)
Runny nose
No 161 (72.2) 166 (68.6) 0.722 .396
Yes 62 (27.8) 76 (31.4)
Sneeze
No 202 (90.6) 226 (93.4) 1.247 .264
Yes 21 (9.4) 16 (6.6)
Diarrhea
No 221 (99.1) 239 (98.8) 0.128 .720
Yes 2 (0.9) 3 (1.2)
Vomit
No 222 (99.6) 242 (100) 1.088 .297
Yes 1 (0.4) 0 (0)

Abbreviation: HRV, human rhinovirus.

3.5. Clinical characteristics of virus infections

We nest analyzed the clinical characteristics of the patients we tested, and found that there was a higher rate of fever (χ 2 = 11.271, p = .001), cough (χ 2 = 6.987, p = .008), runny nose (χ 2 = 7.980, p = .005), and sneeze (χ 2 = 4.676, p = .031) in the positive ones of the infected (Table 5).

TABLE 5.

The clinical characteristics of the HRV‐tested patients in the outbreaks.

Negative Positive χ 2 P
Age
Average 11.03 13.4
Sex
Male 91 (67.9) 53 (59.6) 1.634 .201
Female 43 (32.1) 36 (40.4)
Fever
No 63 (47.0) 22 (24.7) 11.271   .001
Yes 71 (53.0) 67 (75.3)
Cough
No 120 (89.6) 68 (76.4) 6.987 .008
Yes 14 (10.4) 21 (23.6)
Sore throat
No 105 (78.4) 60 (67.4) 3.328 .068
Yes 29 (21.6) 29 (32.6)
Muscle pain
No 133 (99.3) 89 (100) 0.667 .414
Yes 1 (0.7) 0 (0)
Headache
No 125 (93.3) 80 (89.9) 0.831 .362
Yes 9 (6.7) 9 (10.1)
Conjunctival congestion
No 134 (100) 89 (100)
Yes 0 (0) 0 (0)
Runny nose
No 106 (79.1) 55 (61.8) 7.980 .005
Yes 28 (21.9) 34 (32.8)
Sneeze
No 126 (94.0) 76 (85.4) 4.676 .031
Yes 8 (6.0) 13 (14.6)
Diarrhea
No 133 (99.3) 88 (98.9) 0.086 .770
Yes 1 (0.7) 1 (1.1)
Vomit
No 133 (99.3) 89 (100) 0.667 .414
Yes 1 (0.7) 0 (0)

Abbreviation: HRV, human rhinovirus.

4. DISCUSSION

The “common cold” was not generally concerned by the general public for the mild symptoms; however, there were more than 250 virus serotypes that could lead to the “common cold” symptoms, and HRV has long been known as the main pathogens of the “common cold,” 2 , 9 Cui et al. 10 have reported that among the influenza‐like illness, 6.46% of which were tested positive for HRV, another study conducted by Zhao et al. 11 reported that 11.28% of the acute respiratory viral infection were caused by HRV infection. Furuse et al. 12 also found that rhinoviruses were the most frequently detected pathogen (22.2%) among the acute respiratory infection cases, the hospitalized population would have a higher positive rate of HRV. 13

A study conducted by Dr. Luka et al. 14 in Kenya reported that the common cold caused by HRV was mainly detected among school‐going children or teenagers with mild acute respiratory symptoms. However, the HRV‐infected adults had relatively higher mortality and longer hospitalization than the patients infected with IFVs in the elderly population. 15 Dr. Park et al. 16 analyzed the etiological surveillance data of respiratory viruses in South Korea from 2016 to 2019 and 2020 and found that the enveloped respiratory viruses (human coronavirus; non‐SARS‐COV‐2; HMPV; IFV; PIV; and RSV) were effectively controlled at the COVID‐19 control measures in 2020, while non‐enveloped respiratory viruses (ADV; HRV; and human bocavirus) were not effectively controlled during this period, and among hospitalized cases, the proportion of hospitalizations due to rhinovirus infection was significantly increased. A study conducted by Dr. Zhang et al. 17 observed a sharp increase in the positive rate of HRV in Beijing, China, and reasonably assumed to be explained by the reopening of the primary and secondary schools in Beijing. Studies conducted in Shanghai, China, America, and German showed that HRV stayed low in the first quarter of 2020, and raised rapidly in June, matches our study, and observed relatively higher morbidity in the rest of the year. 18 , 19 , 20 , 21 Another study 22 conducted in Southampton, UK, gave a theory that the HRV was mainly found in children and adolescents who were the major reservoir for HRV infection, social distancing and face masks are not effective in preventing transmission of HRV, with “Back‐to‐School Upper Respiratory Infection” effect, 23 the risk of HRV transmission surges after schools reopening. On the other hand, Dr. Leung et al. 24 conducted experiments and proved that there was no significant difference in filtering or protection effect of HRV between wearing a face mask or not, indicating that wearing masks cannot effectively protect the population from the HRV infection.

Our previous studies 25 , 26 , 27 have shown that when combated with the COVID‐19 pandemic, measures had been taken to stop the transmission of the SARS‐COV‐2, and respiratory viruses like the influenza virus, varicella, herpes zoster, rubella, measles, mumps virus were observed all dramatically decreased during the fighting against COVID‐19 pandemic; however, HRV was found remains prevalent in school teenagers. 28

In our study, most of the outbreaks were reported the primary and secondary schools of Guangzhou, which was agreed with Dr. Luka et al. 14  and Dr. Zhang et al. study. 17 Seventy‐four percent of the patients in our study were recorded to have a fever, 30% of the patients had a sore throat and runny nose, 19% of the patients had a cough, and 8% of the patients had sneezing, so the most typical symptom of HRV infection in our study was fever. By sampling and testing, we found that patients with the symptoms of fever, cough, runny nose, and sneezing were more likely to test positive for HRV in an HRV‐related outbreak. Studies have proved that HRV infection in youngsters would be symptomatic while in adults often asymptomatic. 29 However, as we illustrated in Table 4, the tested patients had a higher proportion of fever, which would sure be selection bias, because the strategy during the control of the outbreaks is to identify the pathogens and control the spreading, so we were more likely to take the specimens of the patients with obvious symptoms instead of collecting samples of all patients, to improve the detection success rate.

Diurnal temperature range (DTR) was reported to be one of the risk factors of the common cold, which gives the answer to the trend of the endemic of HRV in spring and winter of the year. 30 Obesity was another risk factor reported to rise the possibility of HRV infection. 31 While in our study, we did not collect the DTR, height, and weight data of the patients, which is a shortcoming of this study.

In summary, this study gives a glimpse of the endemic of HRV in Guangzhou, proved better evidence for the prevention and control of respiratory viruses, and indicated that the conventional COVID‐19 control measures, such as wearing face masks or social distancing, are not effective enough in preventing rhinovirus, so new masks that filter nonenveloped viruses, including HRV, should be considered as a possible new approach to preventing HRV infection.

AUTHOR CONTRIBUTIONS

Di Wu,Jianyun Lu and Tiantian Wu: Conceptualization and investigation of the original draft. Tiantian Wu, Qing Zeng, and Yiyun Chen: Methodology. Yanhui Liu: Data curation. Di Wu and Jianyun Lu: Review and editing.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

ACKNOWLEDGMENTS

This study was supported by the Natural Science Foundation of Guangdong Province (2019A1515011407), the Medical Science and Technology Project of Guangzhou (20201A011067 and 20211A011059), and the Guangdong Medical Science and Technology Research Project (A2019379, A2020399, and B2021244).

Lu J, Wu T, Zeng Q, Chen Y, Liu Y, Wu D. Epidemiology of rhinovirus under the COVID‐19 pandemic in Guangzhou, China, 2020. Immun Inflamm Dis. 2022;10:e632. 10.1002/iid3.632

DATA AVAILABILITY STATEMENT

Raw data were generated during the field investigation. Derived data supporting the findings of this study are available from the corresponding author on request.

REFERENCES

  • 1. Jans DA, Ghildyal R. Rhinoviruses. In: Jans DA, ed. Methods in Molecular Biology. Springer; 2015. [DOI] [PubMed] [Google Scholar]
  • 2. Jacobs SE, Lamson DM, George K St, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26:135‐162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Smith ME, Wilson PT. Human rhinovirus/enterovirus in pediatric acute respiratory distress syndrome. J Pediatr Intensive Care. 2020;9:81‐86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Takashita E, Kawakami C, Momoki T, et al. Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic. Influenza Other Respir Viruses. 2021;15:488‐94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Champredon D, Bancej C, Lee L, Buckrell S. Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID‐19 pandemic in Canada. Influenza Other Respir Viruses. 2021;16:190‐192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kim HM, Lee EJ, Lee NJ, et al. Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea. Influenza Other Respir Viruses. 2021;15:721‐31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. Lancet Microbe. 2020;1:e254‐e262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Piret J, Boivin G. Viral interference between respiratory viruses. Emerg Infect Dis. 2022;28:273‐281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Lewis‐Rogers N, Seger J, Adler FR. Human rhinovirus diversity and evolution: how strange the change from major to minor. J Virol. 2017;91:e01659‐e01716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cui X, Teng Z, Zhou Y, Zhao X, Zhang X. Prevalence and genotyping characters of human rhinovirus among influenza‐like illness patients in Shanghai in 2018. Int J Virol. 2020;27:279‐282(in Chinese). [Google Scholar]
  • 11. Zhao L, Fang X, Wang M, Liu Y, Chen Y, Jiang H. Epidemiological investigation of 452 children with acute respiratory viral infection. Chin J Woman Child Health Res. 2020;31:722‐726 (in Chinese). [Google Scholar]
  • 12. Furuse Y, Tamaki R, Suzuki A, et al. Epidemiological and clinical characteristics of children with acute respiratory viral infections in the Philippines: a prospective cohort study. Clin Microbiol Infect. 2021;27:1037. [DOI] [PubMed] [Google Scholar]
  • 13. Peltola V, Waris M, Osterback R, Susi P, Hyypia T, Ruuskanen O. Clinical effects of rhinovirus infections. J Clin Virol. 2008;43:411‐414. [DOI] [PubMed] [Google Scholar]
  • 14. Luka MM, Kamau E, Adema I, et al. Molecular epidemiology of human rhinovirus from 1‐year surveillance within a school setting in rural coastal Kenya. Open Forum Infect Dis. 2020;7:ofaa385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Hung IF, Zhang AJ, To KK, et al. Unexpectedly higher morbidity and mortality of hospitalized elderly patients associated with rhinovirus compared with influenza virus respiratory tract infection. Int J Mol Sci. 2017;18:259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Park S, Michelow IC, Choe YJ. Shifting patterns of respiratory virus activity following social distancing measures for COVID‐19 in South Korea. J Infect Dis. 2021;224:1900‐1906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Zhang RX, Chen DM, Qian Y, et al. Surges of hospital‐based rhinovirus infection during the 2020 coronavirus disease‐19 (COVID‐19) pandemic in Beijing, China. World J Pediatr. 2021;17:590‐596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Jia R, Lu L, Li S, et al. Human rhinoviruses prevailed among children in the setting of wearing face masks in Shanghai, 2020. BMC Infect Dis. 2022;22:253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Maison N, Peck A, Illi S, et al. The rising of old foes: impact of lockdown periods on "non‐SARS‐CoV‐2" viral respiratory and gastrointestinal infections. Infection. 2022;50:519‐524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Jiang H, Yang T, Yang C, et al. Molecular epidemiology and clinical characterization of human rhinoviruses circulating in Shanghai, 2012‐2020. Arch Virol. 2022;167:1111‐1123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Uhteg K, Amadi A, Forman M, Mostafa HH. Circulation of non‐SARS‐CoV‐2 respiratory pathogens and coinfection with SARS‐CoV‐2 amid the COVID‐19 pandemic. Open Forum Infect Dis. 2022;9:ofab618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Poole S, Brendish NJ, Tanner AR, Clark TW. Physical distancing in schools for SARS‐CoV‐2 and the resurgence of rhinovirus. Lancet Resp Med. 2020;8:e92‐e93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Perry Markovich M, Glatman‐Freedman A, Bromberg M, et al. Back‐to‐school upper respiratory infection in preschool and primary school‐age children in Israel. Pediatr Infect Dis J. 2015;34:476‐481. [DOI] [PubMed] [Google Scholar]
  • 24. Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Med. 2020;26:676‐680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Wu D, Ma X, Geng H, et al. Reduction in mumps during the fight against the COVID‐19 pandemic. Asia Pac J Public Health. 2021;33:171‐173. [DOI] [PubMed] [Google Scholar]
  • 26. Wu D, Lu J, Liu Y, Zhang Z, Luo L. Positive effects of COVID‐19 control measures on influenza prevention. Int J Infect Dis. 2020;95:345‐346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Wu D, Liu Q, Wu T, Wang D, Lu J. The impact of COVID‐19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China. Immun Inflamm Dis. 2020;8:844‐846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Wu D, Lu J, Sun Z, et al. Rhinovirus remains prevalent in school teenagers during fight against COVID‐19 pandemic. Immun Inflamm Dis. 2020;9:76‐79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, Hyypia T. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis. 2008;197:382‐389. [DOI] [PubMed] [Google Scholar]
  • 30. Ma Y, Yang S, Yu Z, et al. Effect of diurnal temperature range on outpatient visits for common cold in Shanghai, China. Environ Sci Pollut Res Int. 2020;27:1436‐1448. [DOI] [PubMed] [Google Scholar]
  • 31. Orozco‐Hernandez JP, Montoya‐Martinez JJ, Pacheco‐Gallego MC, Cespedes‐Roncancio M, Porras‐Hurtado GL. SARS‐CoV‐2 and rhinovirus/enterovirus co‐infection in a critically ill young adult patient in Colombia. Biomedica. 2020;40:34‐43. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Raw data were generated during the field investigation. Derived data supporting the findings of this study are available from the corresponding author on request.


Articles from Immunity, Inflammation and Disease are provided here courtesy of Wiley

RESOURCES